Vasoptic Medical Inc. is a medical device company developing and commercializing high-quality, cost-effective products for the non invasive, dynamic assessment of retinal blood flow and vascular status. Vasoptic Medical has developed a low-cost, portable, noninvasive retinal imaging instrument (the XyCAM), which can complement fundus photographs with retinal blood flow information obtained at high spatio-temporal resolution without the introduction of any dyes. This handheld retinal imager has the potential to help detect a number of clinical conditions, including diabetic retinopathy (DR), glaucoma, and age-related macular degeneration. Early detection can often prevent vision loss. The XyCAM device is being designed to detect these conditions inn their earliest stages to help healthcare providers manage and prevent DR and glaucoma progression through a convenient, low-cost, minimally invasive procedure.

CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound. The company’s CoapTech Carrier™ is a novel platform technology combining magnetic attraction for device placement guidance and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures.

CoapTech is commercializing a kit that will enable clinicians to perform a novel procedural method called Percutaneous Ultrasound Gastrostomy (PUG) for the placement of semi-permanent feeding tubes in the stomach. PUG improves on Percutaneous Endoscopic Gastrostomy (PEG), the current standard of care for feeding tube placement. The company believes that PUG is a safer, simpler, and less expensive method for placing feeding tubes.

CoolTech develops and commercializes products utilizing an internal evaporative cooling technology licensed from Johns Hopkins University. CoolTech has an exclusive, perpetual, worldwide license for this technology, which was formally executed in April, 2012.